Trident Lifeline Limited

₹424.15As of Sun 8 Nov 2026, 12:00 UTC
BSE:543616Healthcare
Country India
PE (Fwd) •••
TSR 4Y CAGR 32.02%
Div yield 0.24%
ROE 23.62%
Pharmaceutical Preparations
Beta (5Y) (0.36)
PE TTM 21.57
TSR TTM 41.55%
Mkt cap ₹5.061B
ROIC 12.23%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹406
(4.23%)
(66.34%)
Sell 0|0|9|1|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
6.23
6.51
7.04
7.23
37.39%
41.33%
37.66%
28.58%
Revenue₹M
250.0
243.9
241.7
241.9
2.36%
(2.37%)
(0.47%)
(1.55%)
Peers (US$52.57M)
Cap (US$)
PE
86.44M
26.89x
37.50M
74.64x
Capital
TTM
5Y
10Y
Leveragex
0.530
0.817
0.795
EBIT/Intx
0.547
0.097
0.101
Own earn%
(224.42)
26.46
29.42
Sh yield%
37.59
27.76
22.58
Owners
Insiders/Inst%
14.07
48.51
Short interest%
0.66
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
34–44
$1 testx
—
Incr. ROIC%
4